TMCnet News
UCB Inc. Implements Cegedim Relationship Management Mobile Intelligence Cloud Platform, Enhancing Customer EngagementCegedim Relationship Management, a technology information services company delivering innovation to help transform commercial, compliance, and medical operations in U.S. healthcare, today announced that UCB Inc., a biopharmaceutical leader for severe diseases in the therapeutic areas of central nervous system and immunology, has enhanced customer engagement by deploying Mobile Intelligence for over 700 specialty sales representatives and medical scientific liaisons. Increasing Stakeholder Engagement while Enhancing Commercial Operations As the healthcare industry continues to evolve and increase in complexity considering multiple stakeholders, more specialized markets, increasing regulation and budgetary restrictions, leading Biopharmaceutical companies seek a more efficient way to collaborate that adds value while improving the efficiency of their commercial operations. UCB Inc., the U.S.-based subsidiary of UCB S.A. with Headquarter in Belgium, has recently completed the deployment of Cegedim's Customer Relationship Management (CRM), Mobile Intelligence and Closed Loop Marketing (CLM) on Apple's (News - Alert) iPad* devices, which has allowed for consolidation from three separately sourced applications to one integrated multichannel platform. "This project exemplifies the next generation of technology that moves beyond just solving problems to now delivering value to healthcare professionals and patients. I have been very pleased with the successful execution of the project," said Miguel Louzan, Vice President of Global Information Technology at UCB. "Our teams at UCB and Cegedim have worked very well together in a true partnership. They have delivered an on-time and on-budget strategic initiative that has yielded significant process improvements and cost optimization in our commercial operations." "UCB has a unique vision and strategy in terms of customer engagement and I am honored Cegedim has been given the opportunity to support the execution of this multichannel and multi-stakeholder strategy throughout the U.S. and Canada," stated Angela Miccoli, President of Cegedim North America. "Through the deployment Mobile Intelligence CRM and CLM, UCB has further embraced a single cloud-platform approach that already leverages Cegedim's resource allocation application, in Organization Manager, and the worldwide leading healthcare customer reference database, in OneKey." The promise to deliver the right message, to the right stakeholder at the right time and in the right context with compliance at the core paves the way to a biopharmaceutical commercial model where the technology drives as much value for healthcare providers and patients, as it does for the industry. Mobile Intelligence is a leading cloud technology platform hosting an ecosystem of channel interaction capabilities ranging from CRM, CLM, social, call center, remote interactions, secured emails, paperless event management and other rich media engagement mechanisms to empower pharmaceutical sales representatives, Medical Science Liaisons (MSLs), Key Account Managers (KAMs), managed markets teams, customer service and marketing professionals. Mobile Intelligence serves as the single information and technology platform delivering flexibility, configurability, and integration to successfully lead the industry in enabling the next generation of engagement in the pharmaceutical commercial model. At the core, Cegedim differentiates by concurrently solving the multichannel and multi-stakeholder paradigm shifts for the Life Sciences industry on iOS or Windows devices regardless on the presence or quality of a device's wireless connection. * iPad is a trademark of Apple Inc.
|